Page last updated: 2024-09-02

triptolide and Parkinson Disease

triptolide has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, L; Huang, YY; Wang, XM; Xia, N; Yang, HM; Zhang, H; Zhang, JN; Zhang, Q; Zhang, YN1
Hao, J; Li, J1
Li, F; Lu, L; Wang, X1
Li, FQ; Liang, XB; Liu, XY; Wang, JJ; Wang, X; Wang, XM; Zhou, HF1

Reviews

3 review(s) available for triptolide and Parkinson Disease

ArticleYear
Treatment of Neurodegenerative Diseases with Bioactive Components of
    The American journal of Chinese medicine, 2019, Volume: 47, Issue:4

    Topics: Alzheimer Disease; Animals; Diterpenes; Epoxy Compounds; Humans; Medicine, Chinese Traditional; Molecular Conformation; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Phenanthrenes; Phytotherapy; Tripterygium; Triterpenes

2019
Novel anti-inflammatory and neuroprotective agents for Parkinson's disease.
    CNS & neurological disorders drug targets, 2010, Volume: 9, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Brain; Cytoprotection; Diterpenes; Encephalitis; Epoxy Compounds; Glatiramer Acetate; Humans; Microglia; Minocycline; Neuroprotective Agents; Parkinson Disease; Peptides; Phenanthrenes

2010
Therapeutic strategies for Parkinson's disease: the ancient meets the future--traditional Chinese herbal medicine, electroacupuncture, gene therapy and stem cells.
    Neurochemical research, 2008, Volume: 33, Issue:10

    Topics: Animals; Diterpenes; Electroacupuncture; Epoxy Compounds; Genetic Therapy; Glutamate Decarboxylase; Humans; Medicine, Chinese Traditional; Parkinson Disease; Phenanthrenes; Stem Cell Transplantation

2008

Other Studies

1 other study(ies) available for triptolide and Parkinson Disease

ArticleYear
Triptolide up-regulates metabotropic glutamate receptor 5 to inhibit microglia activation in the lipopolysaccharide-induced model of Parkinson's disease.
    Brain, behavior, and immunity, 2018, Volume: 71

    Topics: Animals; Cell Line; Disease Models, Animal; Diterpenes; Dopaminergic Neurons; Epoxy Compounds; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophage Activation; Male; Mice; Microglia; Nitric Oxide; Nitric Oxide Synthase Type II; Parkinson Disease; Phenanthrenes; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Signal Transduction; Transcriptional Activation; Tumor Necrosis Factor-alpha; Up-Regulation

2018